Investigation of the efficacy and safety of lung biopsy plus microwave ablation for a solitary suspected malignant pulmonary nodule after radical mastectomy

Investigation of the efficacy and safety of lung biopsy plus microwave ablation for a solitary suspected malignant pulmonary nodule after radical mastectomy

PurposeTo evaluate the safety and efficacy of CT-guided lung biopsy combined with microwave ablation (MWA) for solitary suspected malignant pulmonary nodules in post-radical surgery breast cancer patients.Materials and methodsThis retrospective study included 37 post-radical surgery breast cancer pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Chao Xing, Peishun Li, Sen Yang, Qirong Man, Xusheng Zhang, Qianqian Yuan, Miaomiao Hu, Yunling Bai, Kaixian Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Oncology
Subjects:
lung biopsy
microwave ablation (MWA)
pulmonary nodule
breast cancer
lung metastases
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1525114/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:PurposeTo evaluate the safety and efficacy of CT-guided lung biopsy combined with microwave ablation (MWA) for solitary suspected malignant pulmonary nodules in post-radical surgery breast cancer patients.Materials and methodsThis retrospective study included 37 post-radical surgery breast cancer patients with solitary suspected malignant pulmonary nodules, treated with CT-guided lung biopsy and MWA between January 2014 and December 2018. Institutional review board approval was obtained. Clinical outcomes and complications were analyzed.ResultsPathological results identified primary lung cancer in 5 patients (13.5%, 5/37) and metastatic invasive ductal carcinoma (breast origin) in 30 patients (81.1%, 30/37). Major complications included pneumothorax (n=8, 21.6%), chest pain (n=6, 16.2%), and hemoptysis (n=4, 10.8%). For metastatic cases, 2-, 3-, and 5-year survival rates were 86.2%, 58.3%, and 35.3%, respectively. The median progression-free survival after MWA was 35 months (range: 4–72; 95% CI: 24.53–46.48), and median overall survival was 44 months (95% CI: 32.55–55.45).ConclusionCT-guided lung biopsy combined with MWA is a safe and effective approach for managing solitary suspected malignant pulmonary nodules in post-radical surgery breast cancer patients.
ISSN:2234-943X

Similar Items